Polynovo Ltd (ASX: PNV) Share Price and News

Price

$1.18

Movement

0.085 (-6.72%)

as at 13 Jun - Closed (20 mins delayed)

52 Week Range

$0.93 - $2.78

 
1 Year Return

-50.0%

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $815.19 million
P/E Ratio 155.36
Dividend Yield 0.00%
Shares Outstanding 690.84 million
Earnings per share 0.008
Dividend per share N/A
Year To Date Return -36.03%
Earnings Yield 0.64%
Franking -
Share Price

$1.18

Day Change

0.085 (-6.72%)

52 Week Range

$0.93 - $2.78

Yesterday's Close

$1.265

Today's Open

$1.265

Days Range

$1.155 - $1.265

Volume

3,105,313

Avg. Volume (1 month)

2,169,971

Turnover

$3,705,063

as at 13 Jun - Closed

  • Polynovo Ltd (ASX: PNV)
    Latest News

    Piggy bank sinking in water symbolising a record low share price.
    52-Week Lows

    16 ASX 200 shares that hit multi-year lows on Friday

    Markets are nervous as US President Donald Trump winds back tariffs on some Canadian and Mexican imports.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Capricorn, CBA, Endeavour, and Polynovo shares are tumbling today

    These shares are ending the week in the red. But why?

    Read more »

    Man standing on rock next to turquoise salt lagoon.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a pleasant start to the week for investors today.

    Read more »

    A business woman looks unhappy while she flies a red flag at her laptop.
    Share Fallers

    These were the worst-performing ASX 200 shares in February 2025

    These shares were sold off last month. Let's see what happened to them.

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Domino's, Johns Lyng, Polynovo, and Praemium shares are dropping today

    These shares are having a tough time on Tuesday. But why?

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Earnings Results

    Why has this ASX 200 healthcare stock crashed 24% in 2 days?

    It has been a tough start to the week for this medical device company's shareholders.

    Read more »

    Happy shareholders clap and smile as they listen to a company earnings report.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a momentous day for ASX shares, with the index hitting another record...

    Read more »

    Two lab workers fist pump each other.
    Healthcare Shares

    2 buy-rated ASX 200 healthcare shares to bring your portfolio to life in 2025

    Bell Potter is expecting healthy returns from these stocks this year.

    Read more »

    Ten happy friends leaping in the air outdoors.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was a day of relief and optimism for the S&P/ASX 200 Index (ASX: XJO)  and ASX investors this Tuesday.…

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

    These shares are having a better day than most today. But why?

    Read more »

    Man drawing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

    These shares are starting the week positively. But why?

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    The best ASX 200 healthcare stocks to buy in 2025

    These shares could give your portfolio a healthy boost next year according to Bell Potter.

    Read more »

    Frequently Asked Questions

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    21st May 2025 2025-05-21T16:21:40 Becoming a substantial holderYesNo4:21pm17695k
    16th May 2025 2025-05-16T15:06:39 Webcast Recording - Investor UpdateYesNo3:06pm1227k
    16th May 2025 2025-05-16T08:23:27 Investor Presentation & Webcast LinkYesNo8:23am7799k
    13th May 2025 2025-05-13T13:26:35 BTM delivers positive First in Man results in Cell TherapiesYesNo1:26pm4391k
    12th May 2025 2025-05-12T16:18:47 Trading HaltYesNo4:18pm2263k
    12th May 2025 2025-05-12T14:44:07 TGA Clearance for NovoSorb MTX (4 mm and 6 mm)YesNo2:44pm2226k
    7th May 2025 2025-05-07T13:28:14 PolyNovo presents at Macquarie Australia ConferenceYesNo1:28pm91.7M
    1st May 2025 2025-05-01T16:46:02 Investor Update Webinar - 16 May 2025YesNo4:46pm2279k
    22nd Apr 2025 2025-04-22T15:16:01 Change in substantial holdingYesNo3:16pm252.3M
    22nd Apr 2025 2025-04-22T08:21:59 Change in substantial holdingYesNo8:21am251.7M

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    12 Jun 2025 $1.27 $-0.04 -3.07% 2,335,785 $1.30 $1.30 $1.26
    11 Jun 2025 $1.31 $-0.04 -2.97% 2,589,203 $1.36 $1.38 $1.30
    10 Jun 2025 $1.35 $0.03 2.29% 1,829,089 $1.31 $1.35 $1.30
    06 Jun 2025 $1.31 $-0.03 -2.24% 1,082,756 $1.36 $1.36 $1.30
    05 Jun 2025 $1.34 $0.03 2.28% 2,733,737 $1.32 $1.37 $1.32
    04 Jun 2025 $1.32 $0.05 3.95% 1,389,990 $1.28 $1.34 $1.28
    03 Jun 2025 $1.27 $0.00 0.00% 1,023,591 $1.27 $1.28 $1.25
    02 Jun 2025 $1.26 $-0.05 -3.82% 1,312,053 $1.32 $1.33 $1.26
    30 May 2025 $1.31 $0.01 0.77% 1,742,811 $1.30 $1.33 $1.28
    29 May 2025 $1.31 $0.01 0.78% 740,284 $1.29 $1.32 $1.29
    28 May 2025 $1.29 $0.01 0.78% 1,633,894 $1.30 $1.33 $1.29
    27 May 2025 $1.29 $-0.02 -1.54% 2,411,210 $1.31 $1.32 $1.26
    26 May 2025 $1.30 $0.00 0.00% 1,242,079 $1.31 $1.32 $1.28
    23 May 2025 $1.31 $-0.01 -0.76% 1,507,695 $1.31 $1.32 $1.28
    22 May 2025 $1.31 $-0.05 -3.66% 2,629,588 $1.35 $1.36 $1.29
    21 May 2025 $1.37 $-0.01 -0.73% 1,816,547 $1.38 $1.41 $1.36
    20 May 2025 $1.38 $-0.06 -4.18% 3,415,741 $1.42 $1.43 $1.36
    19 May 2025 $1.44 $-0.05 -3.36% 2,163,444 $1.51 $1.53 $1.41
    16 May 2025 $1.49 $0.00 0.00% 1,911,607 $1.50 $1.53 $1.46
    15 May 2025 $1.49 $-0.02 -1.32% 2,369,534 $1.50 $1.54 $1.46
    14 May 2025 $1.51 $-0.16 -9.58% 5,691,305 $1.69 $1.72 $1.50

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 Jan 2025 David Williams Sell 750 $1,522
    Off-market trade.
    30 Sep 2024 Andrew Lumsden Sell 50,000 $130,915
    On-market trade.
    26 Sep 2024 Leon Hoare Sell 100,000 $260,839
    On-market trade. As per announcement on 02-01-2024
    13 Sep 2024 Bruce Rathie Sell 750,000 $1,886,900
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams is a director and investment banker with a track record in business development, mergers and acquisitions, and capital raising. He has experience advising companies in the food, medical device, and pharmaceutical sectors. Mr Williams is currently Managing Director of corporate advisory firm Kidder Williams.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott has a track record in product development, clinical trials, regulatory affairs, audits, quality management, project management and operational strategy. Her worldwide experience in new facility delivery, production scale up, strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally. Dr Elliott was Global Head, Strategic Portfolio Management at CSL Behring, a role that is responsible for governance oversight and business value delivery. Dr Elliott is a member of the Risk Committee.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden has more than 20 years of experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer. Prior to joining Wellcom, Mr Lumsden was a Senior Manager within the Audit and Assurance practice of PricewaterhouseCoopers. Mr Lumsden is the Chair of the Risk Committee.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare has expertise across multiple Life Sciences sectors. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew (S&N) ANZ. He served as President of S&N's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly is an IP and business development professional with more than 30 years of local and international experience. She has been on the Board of the Institute of Patent and Trademark Attorneys of Australia for over a decade. Ms Emmanuel-Donnelly was Executive Manager of Business Development and Commercial at the CSIRO, was in-house IP Counsel for Unilever in the U.K., and practiced as a patent and trademark attorney for Wilson Gunn.
    Mr Jan-Marcel Gielen Company Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan Gielen Chief Financial Officer
    -
    Philip Scorgie Chief Information Officer
    -
    Joseph Amaral Chief Medical Officer (part-time)
    -
    Ingrid Anderson Chief People Officer
    -
    David McQuillan Chief Technical and Scientific Officer
    -
    Jan-Marcel Gielen Company Secretary
    -
    David Morris President Asia Pacific
    -
    Edward Graubart President North America
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 96,149,727 13.93%
    J P Morgan Nominees Australia Pty Limited 80,078,534 11.60%
    Citicorp Nominees Pty Limited 37,720,578 5.46%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    Lateral Innovations Pty Ltd (Trust A/C 10,924,103 1.58%
    Mr Anthony Shane Kittel Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,050,000 1.17%
    Bnp Paribas Noms Pty Ltd 7,622,413 1.10%
    National Nominees Limited 6,653,041 0.96%
    Netwealth Investments Limited (Wrap Services A/C) 5,394,880 0.74%
    BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient) 4,533,452 0.66%
    BNP Paribas Nominees Pty Ltd (Agency Lending A/C) 4,414,903 0.64%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mrs Li-Hsien Tsai 3,955,424 0.57%
    Mr David Kenley 3,755,000 0.54%
    Mr Paul Gerard Brennan 3,569,796 0.52%
    Mr Matthew James Avery 3,439,332 0.50%
    Mr David Kenley i 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Evan Philip Clucas Ms Leanne Jane Weston (Kuranga Nursery Super A/C) 2,931,149 0.42%
    Mr Chris Dawborn (Haskali Super Fund A/C) 2,870,271 0.42%

    Profile

    since

    Note